INTEGRA LIFESCIENCES HLDGS C - NOTE 0.500% 8/1 Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q3 2025

Type / Class
Debt / NOTE 0.500% 8/1
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of INTEGRA LIFESCIENCES HLDGS C - NOTE 0.500% 8/1 across Reporting Periods

Period Principal Value Change Price (% of par) (Median) Investors
2025 Q3 $0 $0 -$566,169,730 0
2025 Q2 $570,968,000 $566,169,755 -$10,918,094 99.02% 28
2025 Q1 $582,250,000 $571,191,522 +$8,953,912 97.96% 30
2024 Q4 $573,249,000 $552,772,984 -$5,259,582 96.43% 30
2024 Q3 $577,548,451 $549,334,121 +$755,130 95.12% 34
2024 Q2 $579,373,000 $547,328,733 -$14,598,581 94.37% 35
2024 Q1 $609,864,600 $589,220,386 +$1,575,503 95.66% 45
2023 Q4 $600,827,500 $567,615,993 -$2,310,549 94.15% 59
2023 Q3 $602,339,500 $554,351,663 +$28,788,603 91.33% 69
2023 Q2 $573,478,000 $525,375,439 -$9,288,375 91.41% 69
2023 Q1 $579,680,000 $566,778,510 +$21,499,576 97.43% 72
2022 Q4 $545,532,000 $530,174,607 +$15,090,882 97.22% 65
2022 Q3 $550,630,315 $483,076,633 +$17,899,764 87.36% 69
2022 Q2 $538,206,300 $508,477,282 -$36,380,490 94.12% 66
2022 Q1 $546,459,669 $576,126,940 +$3,095,405 105.33% 64
2021 Q4 $537,177,000 $584,770,858 -$11,244,770 108.81% 58
2021 Q3 $550,750,525 $607,643,287 +$12,152,528 110.35% 60
2021 Q2 $542,395,000 $598,387,928 +$48,785,684 110.39% 57
2021 Q1 $519,562,055 $580,933,396 +$575,680,780 111.69% 52